Is Pramlintide legal in Australia?

Pramlintide in Australia at a glance

Classification and note come from the Pramlintide profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.

What this means

• 01

  TGA has approved Pramlintide for at least one labeled indication, so a pharmaceutical-grade product exists in Australia and is dispensed on prescription.

• 02

  Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.

• 03

  Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.

What Pramlintide is

An FDA-approved synthetic amylin analogue used with insulin to improve post-meal glucose control and reduce appetite.

Pramlintide is a synthetic analogue of amylin, a hormone co-secreted with insulin. It is FDA-approved as Symlin alongside mealtime insulin in type 1 and type 2 diabetes, slowing gastric emptying, suppressing glucagon and reducing appetite.

Mechanism: Agonizes amylin receptors to delay gastric emptying, suppress post-meal glucagon, and promote satiety, complementing insulin.

Regulatory history: FDA-approved (Symlin) as an insulin adjunct

How TGA treats this kind of product

Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.

The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for Pramlintide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Pramlintide in other countries

Frequently asked questions

Related compounds in Australia